Susan M. Schneider, PhD, RN, AOCN, ACNS-BC, FAAN

Dr. Schneider is Associate Professor and serves as faculty lead for the graduate oncology specialty at the School of Nursing. She received her doctorate in nursing from Case Western Reserve University, her Master of Science degree from Texas Woman’s University, and her BSN from the University of Akron. Dr. Schneider has extensive experience in pediatric and adult oncology nursing. She holds certification as a clinical nurse specialist and as an advanced oncology certified nurse.


Prior to joining the faculty at Duke University, Dr. Schneider taught in the oncology program at Frances Payne Bolton School of Nursing at Case Western Reserve University, and was a clinical nurse specialist at University Hospitals of Cleveland. She is professionally active in a number of nursing organizations. She has chaired the American Cancer Society Peer Review Committee on Scholarships and Professorships in Oncology Nursing, served as a member of the Oncology Nursing Society (ONS) national board of directors, and is now President-Elect of the ONS. Dr. Schneider has received both the Excellence in Cancer Nursing Research and Excellence in Cancer Nursing Education Awards from the Oncology Nursing Society and is a Fellow of the American Academy of Nursing.


Dr. Schneider's research interests include management of symptom distress in cancer patients, the use of distraction interventions to enhance coping, and the use of tailored protocols to promote chemotherapy adherence.

Academic Program Affiliations
  • PhD in Nursing Program
  • Master of Science in Nursing Program
  • Doctor of Nursing Practice Program
Education
  • PhD - Case Western Reserve University, Frances Payne Bolton School of Nursing
  • MS - Texas Woman's University
  • BSN - The University of Akron
Research Interests

Dr. Schneider’s research interests include the management of symptom distress in cancer patients and the use of distraction interventions to enhance coping. She has conducted a series of four studies exploring the use of a virtual reality distraction intervention to mitigate chemotherapy related symptom distress in adult and pediatric populations.

Current research includes a randomized clinical trial of a tailored intervention protocol designed to promote adherence to oral chemotherapy in adults receiving treatment for breast or colorectal cancer.

Awards and Honors
  • 2012 || 2012 Award for Excellence, Frances Payne Bolton School of Nursing Alumni Association
  • 2008 || Fellow, American Academy of Nursing
  • 2004 || Mary Nowotny Excellence in Cancer Nursing Education Award, Oncology Nursing Society
  • 2003 || Research Mentorship Award, Friends of Nursing, Duke University
  • 2000 || Inducted, Sigma Theta Tau (Beta Epsilon Chapter)
  • 1998 || Benita Martocchio Excellence in Oncology Nursing
  • 1996 || Pediatric Nursing Dissertation Scholarship
  • 1995 || Clinton E. and Vicki A. Lambert Award for Scholarly Writing
  • 1995 || ONS/NCI Research Short Course Participant, Oncology Nursing Society and National Cancer Institute
  • 1994 || American Cancer Society Doctoral Scholarship
  • 1994 || Oncology Nursing Society Doctoral Scholarship
  • 1981 || Inducted, Sigma Theta Tau
Representative Publications
  • 1998 -- Schneider, S. M. Virtual reality. 1998 589-590.
  • 1989 -- Schneider, S. M. Cancer. 1989 .
  • 1993 -- Schneider, S. M. Cancer. 1993 .
  • 2011 -- PubMed # : 21708538 -- Rodriguez, E. S. and Thom, B. and Schneider, S. M. Nurse and physician perspectives on patients with cancer having online access to their laboratory results. Oncol Nurs Forum. 38(4); 476-82.
  • 2011 -- PubMed # : 21514482 -- Schneider, S. M. and Hess, K. and Gosselin, T. Interventions to promote adherence with oral agents. Semin Oncol Nurs. May, 2011 27(2); 133-41.
  • 2010 -- PubMed # : 20797953 -- Gosselin, T. K. and Schneider, S. M. and Plambeck, M. A. and Rowe, K. A prospective randomized, placebo-controlled skin care study in women diagnosed with breast cancer undergoing radiation therapy. Oncol Nurs Forum. September, 2010 37(5); 619-26.
  • 2010 -- PubMed # : 20336327 -- Schneider, S. M. and Kisby, C. K. and Flint, E. P. Effect of virtual reality on time perception in patients receiving chemotherapy. Support Care Cancer. March, 2010 19(4); 555-64.
  • 2008 -- PubMed # : 19064382 -- Smink, K. A. and Schneider, S. M. Overview of stereotactic body radiotherapy and the nursing role. Clin J Oncol Nurs. 12(6); 889-93.
  • 2008 -- Schneider, S. M. and Turner, B. S. and Califf, R. M. and Burks, W. and McHutchinson, J. G. and Gilliss, C. L. Issues in clinical trials management. Academic research units: opportunities and challenges for nursing practice. Research Practitioner. Sep-Oct, 2008 9(5); 175-184.
  • 2007 -- PubMed # : 17878134 -- Gosselin-Acomb, T. K. and Schneider, S. M. and Clough, R. W. and Veenstra, B. A. Nursing advocacy in North Carolina. Oncol Nurs Forum. 34(5); 1070-4.
  • 2007 -- PubMed # : 17562631 -- Schneider, S. M. and Hood, L. E. Virtual reality: a distraction intervention for chemotherapy. Oncol Nurs Forum. 34(1); 39-46. PMC2121303
  • 2005 -- PubMed # : 14722591 -- Schneider, S. M. and Prince-Paul, M. and Allen, M. J. and Silverman, P. and Talaba, D. Virtual reality as a distraction intervention for women receiving chemotherapy. Oncol Nurs Forum. 31(1); 81-8.
  • 2005 -- PubMed # : 16330971 -- Penne, K. and Bolin, C. and Schneider, S. and Allen, D. Gefitinib (Iressa, ZD1839) and tyrosine kinase inhibitors: The wave of the future in cancer therapy. Cancer Nurs. February, 2005 28(6); 481-486.
  • 2005 -- PubMed # : 16355560 -- Rowe, K. and Schneider, S. Profile of cancer-related symptoms prior to chemotherapy. J Support Oncol. Nov.-Dec., 2005 3(6 Suppl 4); 32-33.
  • 2005 -- Schneider, S. M. Using virtual reality as a distraction intervention to mitigate chemotherapy symptoms. 2005 .
  • 2004 -- Schneider, S. M. Chemotherapy distraction. 2004 .
  • 2003 -- PubMed # : 12855087 -- Schneider, S. M. and Ellis, M. and Coombs, W. T. and Shonkwiler, E. L. and Folsom, L. C. Virtual reality intervention for older women with breast cancer. Cyberpsychol Behav. 6(3); 301-7.
  • 2003 -- PubMed # : 14656195 -- Visovsky, C. and Schneider, S. M. Cancer-related fatigue. Online J Issues Nurs. 8(3); 8.
  • 2000 -- PubMed # : 12026359 -- Schneider, S. M. and Workman, M. L. Virtual reality as a distraction intervention for older children receiving chemotherapy. Pediatr Nurs. Nov.-Dec., 2000 26(6); 593-7.
  • 2002 -- PubMed # : 11889684 -- Bender, C. M. and McDaniel, R. W. and Murphy-Ende, K. and Pickett, M. and Rittenberg, C. N. and Rogers, M. P. and Schneider, S. M. and Schwartz, R. N. Chemotherapy-induced nausea and vomiting. Clin J Oncol Nurs. 6(2); 94-102.
  • 2002 -- Schneider, S. M. Infection. The Spectrum. 2002 1.
  • 2002 -- Schneider, S. M. Interventions for clients with hematologic problems. 2002 .
  • 2001 -- PubMed # : 11471117 -- Schneider, S. M. and Hinds, P. S. and Pritchard, M. From single site to societal belief: the impact of pediatric oncology nursing research. J Pediatr Oncol Nurs. August, 2001 18(4); 164-70.
  • 2001 -- Schneider, S. M. Chemotherapy: What the oncology nurse knows. The Spectrum. Summer-Fall, 2001 1-2.
  • 2001 -- Schneider, S. M. Book Review: “Palliative care nursing. Quality of life at the end of life”, by Matzo, M. L. & Sherman, D. W. 2001 6(1); 90-91.
  • 2000 -- PubMed # : 11128121 -- Wonghongkul, T. and Moore, S. M. and Musil, C. and Schneider, S. and Deimling, G. The influence of uncertainty in illness, stress appraisal, and hope on coping in survivors of breast cancer. Cancer Nurs. December, 2000 23(6); 422-9.
  • 2000 -- PubMed # : 10795194 -- Schneider, S. M. I look funny and I feel bad. Measurement of symptom distress. J Child Fam Nurs. July, 2000 2(5); 380-4.
  • 1999 -- PubMed # : 19178248 -- Schneider, S.M. and Workman, M.L. Effects of virtual reality on symptom distress in children receiving chemotherapy. Cyberpsychol Behav. 1999 2(2); 125-134.
  • 1999 -- Wonghongkul, T., Moore, S. M., Musil, C., Schneider, S., & Deimling, G. Relationship among uncertainty in illness, stress appraisal, hope, and coping in breast cancer survivors. The Journal of Nursing Research, Thai Journal (English Language). 1999 3(3); 1-15.
  • 1999 -- Schneider, S. M. Interventions for clients with hematologic disorders. 1999 .
  • 1995 -- Schneider, S. M. Interventions for clients with hematologic disorders 1995 .
  • 1994 -- PubMed # : 8164990 -- Schneider, S. M. Clinical implications for the administration of colony stimulating factors. Orthop Nurs. 13(1); 56-62, 64.
  • 1992 -- PubMed # : 1524943 -- Hawthorne, J. L. and Schneider, S. M. and Workman, M. L. Common electrolyte imbalances associated with malignancy. AACN Clin Issues Crit Care Nurs. 3(3); 714-23.
  • 1992 -- PubMed # : 1504959 -- Radziewicz, R. M. and Schneider, S. M. Using diversional activity to enhance coping. Cancer Nurs. 15(4); 293-8.
  • 1989 -- PubMed # : 2688116 -- Schneider, S. M. and Distelhorst, C. W. Chemotherapy-induced emergencies. Semin Oncol. December, 1989 16(6); 572-8.
  • 1989 -- PubMed # : 2586903 -- Schneider, S. M. and Roe, C. A. and Hawthorne, J. L. Chemotherapy experts. Nursing. November, 1989 19(11); 72-3.
  • 2012 -- PubMed # : 22842691 -- Curcio, K. R. and Lambe, C. and Schneider, S. and Khan, K. Evaluation of a cancer survivorship protocol: transitioning patients to survivors. Clin J Oncol Nurs. August, 2012 16(4); 400-6.
  • 2009 -- PubMed # : 19136332 -- Tranin, A. S. and Schneider, S. M. and Oncology Nursing Society (ONS) Board of Directors, Stand up for your profession. Oncol Nurs Forum. 36(1); 10.
  • 2014 -- Schneider, S. M. and Adams, D. Strategies to improve adherence to oral chemotherapy agents. March, 2014 .
  • 2013 -- PubMed # : 23051869 -- Chang, L. and Schneider, S. M. and Chiang, S. and Horng, C. Implementing an evidence-based risk assessment tool to predict chemotherapy-induced neutropenia in women with breast cancer. Cancer Nurs. May-June, 2013 36(3); 198-205.
  • 2013 -- Horigan, A. E. and Schneider, S. M. and Docherty, S. and Barroso, J. The experience and self-management of fatigue in patients on hemodialysis. Nephrology Nursing Journal. Mar-Apr, 2013 40(2); 113-122.
  • 2013 -- PubMed # : 23697982 -- Prewitt, J. and Schneider, S. and Horvath, M. and Hammond, J. and Jackson, J. and Ginsberg, B. PCA Safety Data Review After Clinical Decision Support and Smart Pump Technology Implementation. J Patient Saf. June, 2013 9(2); 103-9.
  • 2013 -- PubMed # : 23715708 -- Lowery, E. W. and Schneider, S. M. Ruxolitinib: a new treatment for myelofibrosis. Clin J Oncol Nurs. June, 2013 17(3); 312-8.
  • 2014 -- PubMed # : 24480661 -- Hammelef, K. J. and Friese, C. R. and Breslin, T. M. and Riba, M. and Schneider, S. M. Implementing distress management guidelines in ambulatory oncology: a quality improvement project. Clin J Oncol Nurs. February, 2014 18 Suppl 31-6.
  • 2014 -- PubMed # : 24570103 -- Affronti, M. L. and Schneider, S. M. and Herndon 2nd, J. E. and Schlundt, S. and Friedman, H. S. Adherence to antiemetic guidelines in patients with malignant glioma: a quality improvement project to translate evidence into practice. Support Care Cancer. July, 2014 22(7); 1897-905.
  • 2015 -- PubMed # : 26000590 -- Smithson, C. R. and Schneider, S. M. Ibrutinib: a new targeted therapy for hematologic cancers. Clin J Oncol Nurs. June, 2015 19(3); E47-51.
  • 2015 -- PubMed # : 26000578 -- Lassiter, M. and Schneider, S. M. A pilot study comparing the neutropenic diet to a non-neutropenic diet in the allogeneic hematopoietic stem cell transplantation population. Clin J Oncol Nurs. June, 2015 19(3); 273-8.
  • 2014 -- PubMed # : 25089216 -- Schneider, S. M. and Adams, D. B. and Gosselin, T. A tailored nurse coaching intervention for oral chemotherapy adherence. J Adv Pract Oncol. May-June, 2014 5(3); 163-72.
  • 2013 -- PubMed # : 25032022 -- Trotter, K. and Schneider, S. M. and Turner, B. S. Group appointments in a breast cancer survivorship clinic. J Adv Pract Oncol. November-December, 2013 4(6); 423-31.
Grant Funding (Selected)
  • Tailored Adherence Protocol for Oral Chemotherapy
    National Institutes of Health/National Cancer Institute
    1R15-CA139398-01
    04/2009 to 03/2012
    Role: PI
    The aims of this study are to 1) test the effectiveness of a tailored protocol to promote adherence to oral chemotherapeutic agents in adults receiving treatment for breast or colorectal cancer, 2) examine adherence to oral chemotherapeutic agents over time, and 3) examine the effects of age, gender, caregiver availability, personal involvement in health care, and depression on adherence rates to oral chemotherapeutic agents. The tailored adherence protocol is based on the self-regulatory model of adherence. The intervention identifies patient knowledge, behavioral skills, and affective support and tailors adherence strategies or overcomes barriers in each of these three categories. A randomized clinical trial will examine the adherence rates in 150 adults started on a new oral chemotherapeutic agent at Duke University Medical Center. A control group will receive standard chemotherapy education. Participants in the experimental group will receive the standard education, an assessment and the tailored intervention developed by an advanced practice nurse. The intervention will be administered via telephone calls over six months. Patient adherence rates will be measured in both groups at 2, 4 and 6 months using self report, symptom profiles, and pharmacy fill rates.
  • Authorized Agent Controlled Analgesia (AACA) for PBMT
    Duke Translational Nursing Institute
    08/2010 to 08/2011
    Role: co-PI
    This project will demonstrate the feasibility of safely using AACA in the pediatric bone marrow transplant population who are six years old or younger and require analgesia for pain control with an adult, who completes the education and assessment required for AACA.
  • Tailored Adherence Protocol for Oral Chemotherapy
    DUSON Small Grant
    06/2008 to 05/2009
    Role: PI
    Project Goal: The aims of this pilot study are 1) to test the feasibility of administering a tailored protocol to promote adherence to oral chemotherapeutic agents in 20 adults receiving treatment for breast or colorectal cancer and 2) to measure adherence rates to oral chemotherapy in this sample.
  • Advanced Diabetes Management for Nurse Practitioners
    Health Resources and Service Administration (HRSA)
    1D09-HP08059-01-00
    07/2007 to 06/2010
    Role: PI
    Project Goal: Consistent with the legislation of Title VIII and in concert with the goals of Healthy People 2010 and National Goals I -III, the purpose of this new project is to prepare expert advanced practice nurses in the prevention and management of diabetes, particularly in high risk and underserved populations. We plan to use an innovative educative approach that allows those from rural areas to learn medical content regarding health problems that are highly prevalent in their communities, thus increasing the likelihood of graduated nurse practitioner students remaining in these communities to practice. The graduates of this program will be eligible for the American Nurses Credentialing Center (ANCC) exam as Adult or Family Nurse Practitioners. In addition, completion of the proposed Advanced Diabetes Management for Nurse Practitioners will provide students with the necessary didactic content to be eligible for the American Association of Diabetes Educators (AADE) exam to certify them as an Advanced Practitioner in Diabetes Management.
  • Polycystic Ovarian Syndrome: Impact of Flaxseed Supplementation
    Duke Clinical Research Unit
    D972
    07/2007 to 06/2009
    Duke Clinical Translational Science Award D972 by Grant Number 1UL1RR024128-01 from the National Center for Research Resources (NCCR).
  • Effect of Virtual Reality on Symptom Distress in Breast Cancer
    AACN Grant
    04/2006 to 03/2008
    Role: co-PI
    Project Goal: The purpose of this study was to examine the effects of a virtual reality distraction intervention on chemotherapy-related symptom distress levels in 54 women of all ages who were receiving chemotherapy for breast cancer.
  • Effect of Virtual Reality on Symptom Distress in Breast Cancer
    UNC Volunteer Association
    04/2006 to 03/2008
    Role: co-PI
    Project Goal: The purpose of this study was to examine the effects of a virtual reality distraction intervention on chemotherapy-related symptom distress levels in 54 women of all ages who were receiving chemotherapy for breast cancer.
  • Informal Caregiver Training in Cancer Symptom Management
    National Institute of Nursing Research
    1R15 NR009489-01A1
    03/2006 to 08/2008
    Role: Co-Investigator
    Project Goal: The purpose of this study is to examine the effects of experiential symptom management training on self-efficacy and psychological well-being of informal cancer caregivers, and on symptom distress and emergency care use for cancer-related symptoms of their patients.
  • Depression and Quality of Life in Patients with Gliomas
    Oncology Nursing Foundation
    04/2004 to 03/2006
    Role: Co-investigator
    Project Goal: To determine what demographic, diagnostic, or treatment variables are associated with the presence of depression or quality of life symptoms such as fatigue, appetite changes, sleep disturbances or sexual disturbances in adult patients with gliomas.
  • Virtual Reality for Chemotherapy Symptoms
    Oncology Nursing Society Foundation
    RE-12
    10/2002 to 11/2005
    Role: PI
    Project Goal: The purpose of this study is to determine the immediate and short-term (2 days) effects of a single virtual reality intervention on symptom distress levels in adults with lung, colon or breast cancer who are receiving intravenous chemotherapy.
  • AAMC-CDC
    PERT Grant
    09/2001 to 09/2003
    Role: Program Coordinator / Consultant
    The goal of this grant in conjunction with UNC Office of Disabilities and Health and Medical Review of NC will improve breast and cervical cancer screening for women with disabilities statewide.
  • Prophylactic Skin Care for Patients Undergoing Radiation Therapy
    Oncology Nursing Foundation
    03/2002 to 03/2006
    Role: Co-Investigator
    Project Goal: The purpose of this study is to evaluate skin care products that may decrease the incidence of acute skin reactions and/or reduce the severity of the skin reaction from radiation therapy in women with breast cancer. The specific aim is to compare the effectiveness of three different skin care products versus a placebo in prophylactically reducing the incidence and severity of radiation induced skin reactions.
  • Pilot Feasibility Study 1: Trajectories of Aging and Care in Nursing Science
    National Institutes of Health/National Institute of Nursing Research
    1 P20-NR07795-01
    09/2001 to 08/2004
    Role: Pilot PI
    Project Goal: The goal of this study is to examine the effects of a virtual reality distraction intervention on chemotherapy-related symptom distress levels in 20 women aged 50 and older who are receiving chemotherapy for breast cancer.
  • Effect of Virtual Reality on Symptom Distress in Breast Cancer
    Cancer Center at CWRU/UHC, Research Support for Junior Faculty Investigators
    06/1999 to 12/2000
    Project Goal: The goal of this study is to examine the effects of a virtual reality distraction intervention on chemotherapy-related symptom distress levels in 20 women aged 55 and younger who are receiving chemotherapy for breast cancer. Support provided by Cancer Center at CWRU/UHC, Research Support for Junior Faculty Investigators From an American Cancer Society Institutional Research Grant
Scroll back to top automatically